A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age

Clinical trial NCT05575492 · COMPLETED

Trial details

NCT number: NCT05575492
Sponsor: ModernaTX, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cytomegalovirus

Start date: 2022-11-07
Primary completion: 2026-05-12
Enrollment: 873

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.